The regulatory framework in which pharmaceutical companies have to work has changed significantly since the late 1990’s. The development and implementation of risk based approaches to processing pharmaceutical powders allows the pharmaceutical manufacturers the freedom to adopt real-time release for their products whist reducing the regulatory burden for both the statutory bodies and the manufacturers. This thesis has been a collaboration between Buck Systems and the University of Birmingham School of Chemical Engineering to evaluate and develop methods which would enhance the way in which Buck Systems can, in co-operation with their clients, enhance their understanding of how powder properties affect their products that are used in pharmac...
To modernise manufacturing practices and standards, the pharmaceutical industry is undergoing an evo...
Powder blend homogeneity is a critical attribute in formulation development of low dose and potent a...
The powder flowability of active pharmaceutical ingredients and excipients is a key parameter in the...
The regulatory framework in which pharmaceutical companies have to work has changed significantly si...
In the pharmaceutical industry, processing granular materials is inevitable when manufacturing solid...
Powder blend homogeneity is a critical attribute in formulation development of low dose and potent a...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2008.This ele...
Pharmaceutical processing is much more stringent with regulatory requirements for the processing and...
Pharmaceutical manufacturing is experiencing unprecedented scientific and technological innovation i...
Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2009.The primary prereq...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2011.Cataloge...
Approximately 80% of pharmaceutical products and the ingredients required for their manufacture are ...
Dry powder inhaler (DPI) formulations are usually comprised of a mixture of micronised active pharma...
The article describes the development and production of tablets using direct compression of powder m...
Reformulation of blended particulate materials has been always a problem for powder industry because...
To modernise manufacturing practices and standards, the pharmaceutical industry is undergoing an evo...
Powder blend homogeneity is a critical attribute in formulation development of low dose and potent a...
The powder flowability of active pharmaceutical ingredients and excipients is a key parameter in the...
The regulatory framework in which pharmaceutical companies have to work has changed significantly si...
In the pharmaceutical industry, processing granular materials is inevitable when manufacturing solid...
Powder blend homogeneity is a critical attribute in formulation development of low dose and potent a...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2008.This ele...
Pharmaceutical processing is much more stringent with regulatory requirements for the processing and...
Pharmaceutical manufacturing is experiencing unprecedented scientific and technological innovation i...
Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2009.The primary prereq...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2011.Cataloge...
Approximately 80% of pharmaceutical products and the ingredients required for their manufacture are ...
Dry powder inhaler (DPI) formulations are usually comprised of a mixture of micronised active pharma...
The article describes the development and production of tablets using direct compression of powder m...
Reformulation of blended particulate materials has been always a problem for powder industry because...
To modernise manufacturing practices and standards, the pharmaceutical industry is undergoing an evo...
Powder blend homogeneity is a critical attribute in formulation development of low dose and potent a...
The powder flowability of active pharmaceutical ingredients and excipients is a key parameter in the...